- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-6148
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A feline case of multiple myeloma treated with bortezomib ; volume:18 ; number:1 ; day:3 ; month:11 ; year:2022 ; pages:1-6 ; date:12.2022
BMC veterinary research ; 18, Heft 1 (3.11.2022), 1-6, 12.2022
- Creator
-
Tani, Hiroyuki
Miyamoto, Ryo
Miyazaki, Teruki
Oniki, Shingo
Tamura, Kyoichi
Bonkobara, Makoto
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12917-022-03484-1
- URN
-
urn:nbn:de:101:1-2023011820590909671481
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tani, Hiroyuki
- Miyamoto, Ryo
- Miyazaki, Teruki
- Oniki, Shingo
- Tamura, Kyoichi
- Bonkobara, Makoto
- SpringerLink (Online service)
Other Objects (12)
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone
Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
Bortezomib-Induced Perimyocarditis in a Multiple Myeloma Patient: A Case Report
Immune-mediated neuropathy related to bortezomib in a patient with multiple myeloma
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study
Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone
Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
Bortezomib-Induced Perimyocarditis in a Multiple Myeloma Patient: A Case Report
Immune-mediated neuropathy related to bortezomib in a patient with multiple myeloma
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study
Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone
Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
Bortezomib-Induced Perimyocarditis in a Multiple Myeloma Patient: A Case Report
Immune-mediated neuropathy related to bortezomib in a patient with multiple myeloma
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study
Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis